About a third of them do not achieve adequate relief from traditional antidepressant medications and psychotherapy. The Pine ...

Studies show psilocybin from mushrooms could revolutionize depression treatment offering hope to millions who don't respond to traditional medications.

The well-funded biotech lost most of its value after its drug flunked a late-stage trial. One analyst described the results ...

Those on the extreme end of the depression spectrum face symptoms that impact their daily activities too and not just their ...

The participants were implanted with a pacemaker-like device, under the skin in the chest that stimulated their left vagus ...

Participants in clinic trial went from being unable to get out of bed to being productive and interacting with loved ones ...

Neumora Therapeutics Inc.’s shares plummeted after the company’s experimental drug failed to show a benefit in a final-stage ...

Quetiapine is an antipsychotic medication that people who live with schizophrenia or bipolar rely on. Pharmacists say they ...

High frequency TMS tends to increase brain activity, and low frequency TMS tends to suppress it, an effect that gets ...

An international team of researchers conducted a clinical trial on 493 adults whose major depression hadn't previously ...